25 November 2020 in Biomedical Physics & Engineering Express
Aim
: The purpose of the current study was to compare between deep inspiration breath-hold (DIBH) and free-breathing (FB) method in the setup reproducibility and to perform a dosimetric comparison between both methods in left-sided breast cancer patients who undergo the UK FAST trial.
Materials and methods
: The online matching correction data were retrospectively collected for 50 patients treated with the FAST trial. They were equally divided into DIBH and FB groups to compare between both methods in the setup reproducibility and create the appropriate planning target volume (PTV) margin. Ten patients out of the fifty were scanned in DIBH and FB to perform a dosimetric comparison with the strict acceptance criteria of the FAST trial.
Results
: All heart dosimetric parameters of the DIBH was significantly lower than that of FB (p < 0.001), and the lung V 30% of DIBH plans was significantly lower than FB plans (p = 0.03). There was no statistically significant difference between the two methods in the other organs at risk doses. To fulfill the heart and lung constraints in FB plans, the PTV V 90% was reduced by 3.4%, and three plans would not attain the PTV acceptance criteria. There was no significant difference between the systematic or random setup errors between both methods except the left-right random shift was significantly lower in DIBH cases (p = 0.004). The calculated PTV margins were (4 mm, 3 mm, and 4 mm) for DIBH group, and (5 mm, 6 mm, and 8 mm) for FB group in the anterior-posterior, superior-inferior, and left-right shifts, respectively.
Conclusion
: It is highly warranted to treat left-sided breast cancer patients with the DIBH technique when the UK FAST trial is employed for treatment.
30 June 2021 in Biomedical Physics & Engineering Express
Aim . The aim of the current study was to compare between the deep inspiration breath-hold (DIBH) technique and free-breathing (FB) method in the treatment delivery uncertainty of breast cancer radiotherapy using skin dose measurements. Methods . In a prospective manner, eighty patients were randomly selected for skin dose measurements, and they were assigned to two groups. DIBH (40 patients) and FB (40 patients). The systematic inter-fraction dose variation was quantified using the mean percentage error (MPE) between the average measured total dose per session in three consecutive sessions and the corresponding calculated point dose from the treatment planning system. The random inter-fraction dose variation was quantified using the standard deviation (SD) of the dose delivered by the medial or lateral tangential fields, or the total session dose in the three sessions (SD MT , SD LT , or SD total , respectively). While the random intra-fraction dose variation was quantified using the SD of the dose difference between the medial and lateral tangential fields in three consecutive sessions (SD MT-LT ). Results . There was no statistically significant difference in MPE between the DIBH and FB groups (p = 0.583). Moreover, the mean SD total and SD MT of the DIBH group were significantly lower than that of the FB group (2.75 ± 2.33 cGy versus 4.45 cGy ± 4.33, p = 0.048) and (1.94 ± 1.63 cGy versus 3.76 ± 3.42 cGy, p = 0.007), respectively. However, there was no significant difference in the mean SD LT and SD MT-LT between the two groups (p > 0.05). Conclusion . In addition to the advantage of reducing the cardiopulmonary radiation doses in left breast cancer, the DIBH technique could reduce the treatment delivery uncertainty compared to the FB method due to the significant reduction in the random inter-fraction dose variations.
8 February 2024 in Medical Dosimetry
4 June 2026 in Journal of Radiation Research and Applied Sciences